BSECompany UpdateDividend3h ago
AstraZeneca Pharma India Ltd
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
AstraZeneca Pharma India Ltd has announced that it will deduct tax at source on the final dividend for the financial year 2025-26, as per the Finance Act 2020. The dividend will be paid after deducting tax at source under section 393 of the Income Tax Act, 2025. Resident shareholders who do not have a PAN or have an invalid PAN will have 20% tax deducted, while those who provide a self-attested copy of PAN and meet other conditions may be exempt from tax. Non-resident shareholders will have 20% tax deducted, unless they provide a tax treaty benefit certificate.
Read more →📎 1 attachment